Search Saint Luke's

A team of cardiologists has used cardiac imaging technology to confirm that cardiovascular disease was a significant issue thousands of years ago.

Dr. Timothy Bateman spoke with Cardiovascular Business about his group's findings and what it is like to work with flurpiridaz.

Percutaneous coronary intervention is associated with significant short-term improvements in high-risk patients with complex coronary artery disease who are ineligible for coronary artery bypass grafting, according to a new analysis.

Dr. Andrew Sauer wrote an editorial on a newly published study that found more than one in four cardiologists experience mental health conditions.

Semaglutide improves symptoms in both men and women who present with heart failure. When it comes to weight loss, however, the drug appears to benefit women much more than men.

Cardiovascular Business spoke with Dr. Timothy Bateman about his views on SPECT advances and its longevity in the coming years.

TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.

Rehospitalization after aortic valve replacement (AVR) is associated with an increased risk of patient mortality, according to new research.

Growing up next to Saint Luke's Hospital of Kansas City, Leah Suttington knew she wanted to be taken to Saint Luke's when she needed emergency heart care.

The study shows that the diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.